Automated Insulin Delivery Systems Market
完整報告名稱與涵蓋範圍
Automated Insulin Delivery Systems Market Size, Share & Trends Analysis Report, By System Component (Insulin Pumps and Patch Pumps, Continuous Glucose Monitors Integrated with AID, Control Algorithms, Apps and Software, Infusion Sets, Cartridges and Consumables), By System Type (Hybrid Closed-Loop Systems, Advanced Hybrid and Fully Closed-Loop Systems, Interoperable and Open-Protocol Systems), By Indication (Type 1 Diabetes, Insulin-Requiring Type 2 Diabetes, Pediatric and Pregnancy Populations), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The automated insulin delivery systems market covers insulin pumps and patch pumps, the continuous glucose monitors integrated with them, control algorithms and apps and the infusion sets, cartridges and consumables that together automate insulin dosing for type 1 and insulin-requiring type 2 diabetes. Standalone continuous glucose monitors sold without pump integration, insulin pens and smart pens and non-automated pumps are excluded from revenue but analysed as adjacent and feeder categories.
Adoption has accelerated as hybrid closed-loop systems became the standard of care for type 1 diabetes, as tubeless patch pumps and interoperable algorithms lowered barriers and as regulatory clearances extended automated delivery to type 2 diabetes, opening a population several times larger than type 1. Manufacturers are advancing toward fully closed-loop systems that eliminate mealtime announcements, adding dual-hormone approaches, simplifying onboarding for primary care prescribing and expanding pharmacy channel access. Reimbursement expansion for type 2 users, competition with weight-loss and glucose-lowering drugs that delay insulin, cybersecurity requirements and device recalls influence growth, while the continuous glucose monitor partnership landscape determines system availability.
North America is the largest market, with Europe expanding through national reimbursement and Asia Pacific growing from a low base in Japan, China, South Korea and Australia. Competition involves pump leaders, algorithm developers, glucose monitoring companies and Asian patch pump manufacturers.
The InsightAce study delivers revenue forecasts in US$ across all system component, system type, indication and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Automated Insulin Delivery Systems Market Snapshot
Chapter 4. Global Automated Insulin Delivery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By System Component Estimates & Trend Analysis
5.1. System Component & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by System Component:
5.2.1. Insulin Pumps and Patch Pumps
5.2.2. Continuous Glucose Monitors Integrated with AID
5.2.3. Control Algorithms, Apps and Software
5.2.4. Infusion Sets, Cartridges and Consumables
Chapter 6. Market Segmentation 2: By System Type Estimates & Trend Analysis
6.1. System Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by System Type:
6.2.1. Hybrid Closed-Loop Systems
6.2.2. Advanced Hybrid and Fully Closed-Loop Systems
6.2.3. Interoperable and Open-Protocol Systems
Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. Indication & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
7.2.1. Type 1 Diabetes
7.2.2. Insulin-Requiring Type 2 Diabetes
7.2.3. Pediatric and Pregnancy Populations
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Endocrinology Clinics
8.2.2. Home Users
8.2.3. Retail and Specialty Pharmacies
Chapter 9. Automated Insulin Delivery Systems Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Insulet Corporation
11.2. Medtronic plc (Medtronic Diabetes)
11.3. Tandem Diabetes Care, Inc.
11.4. Beta Bionics, Inc.
11.5. Sequel Med Tech, LLC
11.6. Ypsomed AG
11.7. CamDiab Ltd.
11.8. Diabeloop SA
11.9. SOOIL Development Co., Ltd.
11.10. Roche Diabetes Care
11.11. Dexcom, Inc.
11.12. Abbott Laboratories
11.13. EOFlow Co., Ltd.
11.14. Medtrum Technologies Inc.
11.15. Bigfoot Biomedical (Abbott Laboratories)
圖表清單 List of Tables & Figures
Table 1. Global Automated Insulin Delivery Systems Market Revenue Forecast by System Component, 2026-2035 (US$ Mn)
Figure 1. Global Automated Insulin Delivery Systems Market Segmentation and Scope Overview
Table 2. Global Automated Insulin Delivery Systems Market Revenue Forecast by System Type, 2026-2035 (US$ Mn)
Figure 2. Global Automated Insulin Delivery Systems Market Share by System Component, 2026 & 2035
Table 3. Global Automated Insulin Delivery Systems Market Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 3. Automated Insulin Delivery Penetration in Type 1 and Insulin-Requiring Type 2 Diabetes, 2026-2035
Table 4. Global Automated Insulin Delivery Systems Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Algorithm Evolution from Hybrid to Fully Closed-Loop and Dual-Hormone Systems
Table 5. Global Automated Insulin Delivery Systems Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Automated Insulin Delivery Systems Growth Opportunity Analysis
Table 6. North America Automated Insulin Delivery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Automated Insulin Delivery Systems Market Participants
Table 7. Europe Automated Insulin Delivery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Automated Insulin Delivery Systems Market
Table 8. Asia Pacific Automated Insulin Delivery Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Pharmacy Channel and Primary Care Prescribing Expansion for AID Systems
Table 9. Strategic Developments of Leading Automated Insulin Delivery Systems Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們